Cencora’s $460M Volume Drags It to 280th in Market Activity

On October 1, 2025, Cencora (COR) closed with a 0.24% decline, trading at a volume of $0.46 billion, ranking 280th in market activity among listed equities. The stock’s performance reflected broader sector dynamics and strategic updates from the company, which has been navigating post-merger integration challenges and evolving healthcare supply chain demands.

Recent developments highlight Cencora’s focus on streamlining operations and expanding its digital health solutions. The firm has prioritized cost optimization initiatives and technology investments to enhance its pharmacy automation capabilities. Analysts note that these efforts align with long-term goals to strengthen market share in prescription drug distribution, though short-term volatility remains tied to macroeconomic uncertainties and sector-specific regulatory shifts.

To set up this back-test accurately I’ll need a few implementation details that weren’t specified yet. Could you please confirm (or let me know your preference on) the following? 1. Universe • All U.S. listed common stocks, or a narrower index (e.g., Russell 3000, S&P 1500, etc.)? 2. Ranking metric • Rank by share volume or by dollar volume (volume × price)? 3. Trade timing & price • Enter at today’s close and exit at tomorrow’s close, or enter at tomorrow’s open and exit at tomorrow’s close? 4. Weighting scheme • Equal-weight across the 500 names, or weight by volume / market-cap / something else? 5. Transaction costs & slippage • Use zero costs (default) or apply a specific commission/slippage assumption? Once I have those details I can fetch the necessary data, generate the daily signals, and run the portfolio back-test from 2022-01-01 to the present.